Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus

Author： Hiukka A.   Leinonen E.   Jauhiainen M.   Sundvall J.   Ehnholm C.   Keech A.   Taskinen M.  

Publisher： Springer Publishing Company

ISSN： 0012-186X

Source： Diabetologia, Vol.50, Iss.10, 2007-10, pp. : 2067-2075

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prognostic value of QT interval parameters in type 2 diabetes mellitus - Results of a long-term follow-up prospective study

By Cardoso C.R.L.   Salles G.F.   Deccache W.  

Journal of Diabetes and its Complications, Vol. 17, Iss. 4, 2003-07 ,pp. : 169-178

Elsevier

Access to resources Recommend Favorite

QTc interval and resting heart rate as long-term predictors of mortality in type 1 and type 2 diabetes mellitus: a 23-year follow-up

By Stettler C.   Bearth A.   Allemann S.   Zwahlen M.   Zanchin L.   Deplazes M.   Christ E.   Teuscher A.   Diem P.  

Diabetologia, Vol. 50, Iss. 1, 2007-01 ,pp. : 186-194

Springer Publishing Company

Access to resources Recommend Favorite

A New Perspective in the Treatment of Dyslipidemia: Can Fenofibrate Offer Unique Benefits in the Treatment of Type 2 Diabetes Mellitus?

By Steiner George  

Treatments in Endocrinology, Vol. 4, Iss. 5, 2005-01 ,pp. : 311-317

Adis International

Access to resources Recommend Favorite

Long‐Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting

By  

JOURNAL OF THE AMERICAN HEART ASSOCIATION, Vol. 4, Iss. 11, 2015-11 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pleiotropic Effects of PPARγ Agonist on Hemostatic Activation in Type 2 Diabetes Mellitus

By  

Current Vascular Pharmacology, Vol. 11, Iss. 3, 2013-05 ,pp. : 338-351

Bentham Science Publishers

Access to resources Recommend Favorite